EM2202E "Time-Sensitive Decision Making in Severe Heart Failure: STAGE D, SCAI E, IMACS 1, UNOS 2 and More" (IM GR-021122)
Purpose and Overview
The purpose of the talk is to discuss the characteristics of a patient with ACC/AHA Stage D heart failure, including prevalence, exercise capacity, quality of life and advanced therapies including durable mechanical circulatory support and heart transplantation.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe a patient with Stage D heart failure including prevalence estimates.
- Risk-stratify patients with advanced heart failure using exercise testing, quality of life scoring and invasive hemodynamics.
- Review the evolution of durable left ventricular assist device (LVAD) technology in the context of bridge to transplant and destination therapy indications.
- Describe how donor scarcity has impacted allocation for heart transplant, strategy for transplant, limitations of LVAD as BTT and how increasing the organ donor pool may paradoxically increase interest in LVAD implantation rates.
- Remark on ways in which Kinlessness impacts opportunity for advanced therapies creating potential bias in patient selection.
- Remark on how LVAD care in the elderly is fragmented and in need of re-assessment.
- 1.00 AMA